Skip to main content
. 2024 Mar 22;102:105073. doi: 10.1016/j.ebiom.2024.105073

Table 1.

Phenotypic profiling of primary screening strains with twenty antibiotics.

Drug class Drug name K. pneumoniae Ecl8
K. pneumoniae NCTC 13438
A. baumannii NCTC 13424
MIC (mg/L) Interp. MIC (mg/L) Interp. MIC (mg/L) Interp.
Aminoglycosides Amikacin 2 S 64 R >512 R
Apramycina 4 Sc 4 Sc 8 Sc
Gentamicin 1 S 4 R >512 R
Tobramycin 1 S 32 R >512 R
Monobactams Aztreonam 0.25 S >512 R 32 ID
Extended-spectrum cephalosporins Cefepime 0.12 S 128 R 32 R
Cefotaxime 0.06 S 256 R 512 R
Ceftazidime 0.5 S 512 R 64 R
Carbapenems Imipenem 0.25 S 128 R 128 R
Meropenem 0.06 S 128 R 64 R
Phosphonic acids Fosfomycin 64 R 16 S 64 ID
Polymyxins Colistin 4 Sb 2 Sb 4 Sb
Polymyxin B 2 Sc 2 Sc 2 Sc
Phenicols Chloramphenicol 4 S 32 R 64 ID
Fluoroquinolones Ciprofloxacin 0.12 S >512 R 128 R
Levofloxacin 0.12 S 128 R 32 R
DHFR inhibitors Trimethoprim 4 S >512 R 128 R
Sulfonamides Sulfamethoxazole 64 Rc >512 Rc >512 Rc
Tetracyclines Minocycline 2 Sb 4 Sb 4 Sb
Tetracycline 1 Sb 4 Sb 256 Rb

MICs (minimum inhibitory concentrations) were determined using the microbroth dilution method from at least three independent biological replicates. There was no more than one two-fold dilution difference in MICs between biological replicates. MIC values indicated were the most frequently obtained between replicates.

a

HTS control.

b

S/R interpretation based on the EUCAST MIC distribution and epidemiological cut-off (ECOFFS) values.

c

No EUCAST breakpoint available for this drug-bacterial species combination; categorized “S” (sensitive) if ≤4-fold or “R” (resistant) if MIC ≥4-fold the MIC for the relevant susceptible EUCAST QC strain. ID, insufficient EUCAST data to interpret.